Developmental gene expression profiling of mammalian, fetal orofacial tissue

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 12, 2004, Pages 912-926

  Mukhopadhyay, Partha ^a   Greene, Robert M ^a,c   Zacharias, Wolfgang ^b   Weinrich, Martin C ^b   Singh, Saurabh ^a   Young Jr , William W ^a   Pisano, M Michele ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Development; Fetal; Microarray; Orofacial

Indexed keywords

CALCIUM ION; CAVEOLIN; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA BINDING PROTEIN; GALECTIN; GROWTH FACTOR; HEMOGLOBIN; INTEGRIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN; PROTEIN KINASE C; SIALOPROTEIN; SURVIVIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; CLEFT LIP; CLEFT LIP PALATE; CLEFT PALATE; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL GENETICS; DNA MICROARRAY; EMBRYO DEVELOPMENT; ENZYME SUBSTRATE; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; DNA FINGERPRINTING; FACE; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; MICE, INBRED ICR; MODELS, ANIMAL; MOUTH; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

MAMMALIA; MURINAE;

EID: 11144298216     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20095     Document Type: Article

References (106)

1. Alizadeh AA, Eisen MB, Davis RE, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
2. Allan D, Houle M, Bouchard N, et al. 2001. RARgamma and Cdx1 interactions in vertebral patterning. Dev Biol 240:46-60.
3. Altmann CR, Brivanlou AH. 2001. Neural patterning in the vertebrate embryo, Int Rev Cytol 203:447-482.
4. Baggiolini M, Dewald B, Moser B. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97-179.
5. Bahuau M, Houdayer C, Tredano M, Soupre V, Couderc R, Vazquez MP. 2002. FOXC2 truncating mutation in distichiasis, lymphoedema, and cleft palate. Clin Genet 62:470-473.
6. Balasubramanian G, Hanumegowda U, Reddy CS. 2000. Secalonic acid D alters the nature of and inhibits the binding of the transcription factors to the phorbol 12-O-tetradecanoate-13 acetate-response element in the developing murine secondary palate. Toxicol Appl Pharmacol 169:142-150.
7. Balling R, Mutter G, Gruss P, Kessel M. 1989. Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1.1 in transgenic mice. Cell 58:337-347.
8. Barnes JD, Crosby JL, Jones CM, et al. 1994. Embryonic expression of Lim-1, the mouse homolog of xenopus xlim-1, suggests a role in lateral mesoderm differentiation and neurogenesis. Dev Biol 161:168-178.
9. Basilico C, Moscatelli D. 1992. The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165.
10. Baxter RM, Brissette JL. 2002. Role of the nude gene in epithelial terminal differentiation. J Invest Dermatol 118:303-309.
11. Bel-Vialar S, Itasaki N, Krumlauf R. 2002. Initiating Hox gene expression: in the early chick neural tube differential sensitivity to FGF and RA signaling subdivides the HoxB genes in two distinct groups. Development 129:5103-5115.
12. Bell MV, Frampton J. 1999. v-Myb can transform and regulate the differentiation of melanocyte precursors. Oncogene 18:7226-7233.
13. Bittner M, Meltzer P, Chen Y, et al. 2000. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540.
14. Broudy VC, Lin NL, Kaushansky K. 1995. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719-1726.
15. Brown NL, Knott L, Halligan E, et al. 2003. Microarray analysis of murine palatogenesis: Temporal expression of genes during normal palate development. Dev Growth Differ 45:153-165.
16. Brunet CL, Sharpe PM, Ferguson MW. 1995. Inhibition of TGFβS (but not TGFβ1 or TGFβ2) activity prevents normal mouse embryonic palate fusion, Int J Dev Biol. 39:345-355.
17. Bustin SA. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25:169-193.
18. Chavrier P, Vesque C, Galliot B, et al. 1990. The segment-specific gene Krox-20 encodes a transcription factor with binding sites in the promoter region of the Hox-1.4 gene. EMBO J 9:1209-1218.
19. Chen H, Lun Y, Ovchinnikov D, et al. 1998. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 19:51-55.
20. Chiariello M, Marinissen MJ, Gutkind JS. 2000. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol Cell Biol 20:1747-1758.
21. Cho RJ, Huang M, Campbell MJ, et al. 2001. Transcriptional regulation and function during the human cell cycle. Nat Genet 27:48-54.
22. Colognato H, Yurchenco PD. 2000. Form and function: the laminin family of heterotrimers. Dev Dyn 218:213-234.
23. D'Angelo M, Greene RM. 1991. Transforming growth factor-beta modulation of glycosaminoglycan production by mesenchymal cells of the developing murine secondary palate. Dev Biol 145:374-378.
24. D'Angelo M, Chen JM, Ugen K, Greene RM. 1994. TGFβ1 regulation of collagen metabolism by embryonic palate mesenchymal cells. J Exp Zool 270:189-201.
25. Denhardt DT, Noda M, O'Regan AW, et al. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061.
26. El-Hodiri H, Bhatia-Dey N, Kenyon K, et al. 2001. Fox (forkhead) genes are involved in the dorso-ventral patterning of the Xenopus mesoderm. Int J Dev Biol 45:265-271.
27. Faber BC, Cleutjens KB, Niessen RL, et al. 2001. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 89:547-554.
28. Fazioli F, Minichiello L, Matoskova B, et al. 1993. Eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol Cell Biol 13:5814-5828.
29. Ferguson MWJ. 1988. Palate development. Development 103(Suppl):41-60.
30. Fitzpatrick DR, Denhez F, Kondaiah P, Akhurst RJ. 1990. Differential expression of TGF beta isoforms in murine palatogenesis. Development 109:585-595.
31. Francis-West P, Ladher R, Barlow A, Graveson A. 1998. Signalling interactions during facial development. Mech Dev 75:3-28.
32. Galliot B, Dolle P, Vigneron M, et al. 1989. The mouse Hox-1.4 gene: primary structure, evidence for promoter activity and expression during development. Development 107:343-359.
33. Gamer LW, Wright CV. 1993. Murine Cdx-4 bears striking similarities to the Drosophila caudal gene in its homeodomain sequence and early expression pattern. Mech Dev 43:71-81.
34. Gehris AL, Greene RM. 1992. Regulation of murine embryonic epithelial cell differentiation by transforming growth factors beta. Differentiation 49:167-173.
35. Gehris AL, Pisano MM, Nugent P, Greene RM. 1994. Regulation of TGF beta 3 gene expression in embryonic palatal tissue. In Vitro Cell Dev Biol Anim 30A:671-679.
36. Gendron-Maguire M, Mallo M, Zhang M, Gridley T. 1993. Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest. Cell 75:1317-1331.
37. Giachelli CM, Steitz S. 2000. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 19:615-622.
38. Giguere V. 1994. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 15:61-79.
39. Greene RM. 1989. Signal transduction during craniofacial development. Crit Rev Toxicol 20:137-152.
40. Greene RM, Weston W, Nugent P, et al. 1998. Signal transduction pathways as targets for induced embryotoxicity. In: Slikker W, Chang L, editors. Handbook of developmental neurotoxicology. San Diego: Academic Press, pp. 119-139.
41. Greene R, Pisano M. 2000. Pathways to transcription. Teratology 62:10-13.
42. Hartsough MT, Mulder KM. 1995. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 270:7117-7124.
43. Hatakeyama S, Tomichi N, Ohara-Nemoto Y, Satoh M. 2000. The immunohistochemical localization of Fas and Fas ligand in jaw bone and tooth germ of human fetuses. Calcif Tissue Int 66:330-337.
44. Hiraoka A, Yano Ki K, Kagami N, et al. 2001. Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cells. Hematol J 2:307-315.
45. Jay KE, Gallacher L, Bhatia M. 2002. Emergence of muscle and neural hematopoiesis in humans. Blood 100:3193-3202.
46. Karafiat V, Dvorakova M, Pajer P, et al. 2001. The leucine zipper region of Myb oncoprotein regulates the commitment of hematopoietic progenitors. Blood 98:3668-3676.
47. Klee CB, Newton DL. 1985. Calmodulin: An overview. In Paratt J, editor. Control and manipulation of calcium movement. New York: Raven Press, pp 131-146.
48. Lander ES. 1999. Array of hope. Nat Genet 21(Suppl):3-4.
49. Lee FD. 1992. The role of interleukin-6 in development. Dev Biol 151:331-338.
50. Lee MY, Choi JS, Lim SW, et al. 2001. Expression of osteopontin mRNA in developing rat brainstem and cerebellum. Cell Tissue Res 306:179-185.
51. Lehtonen E, Ordonez G, Reima 1. 1988. Cytoskeleton in preimplantation mouse development. Cell Differ 24:165-177.
52. Linask KK, D'Angelo M, Gehris AL, Greene RM. 1991. Transforming growth factor-beta receptor profiles of human and murine embryonic palate mesenchymal cells. Exp Cell Res 192:1-9.
53. MacDonald MR, Baker KS, Schaefer GB. 1997. Marshall-Stickler phenotype associated with von Willebrand disease. Am J Med Genet 68:121-126.
54. Maeda T, Abe M, Kurisu K, et al. 2001. Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J Biol Chem 276:3628-3634.
55. Manser E. 2002. Small GTPases take the stage. Dev Cell 3:323-328.
56. Martin JF, Bradley A, Olson EN. 1995. The paired-like homeobox gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev 9:1237-1249.
57. Mavilio F, Simeone A, Boncinelli E, Andrews PW. 1988. Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. Differentiation 37:73-79.
58. McEvilly RJ, Rosenfeld MG. 1999. The role of POU domain proteins in the regulation of mammalian pituitary and nervous system development. Prog Nucleic Acid Res Mol Biol 63:223-255.
59. McWhirter JR, Goulding M, Weiner JA, et al. 1997. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 124:3221-3232.
60. Mendelsohn C, Lohnes D, Décimo D, et al. 1994. Function of the retinoic acid receptors (RARs) during development. II. Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 12:2749-2771.
61. Middleton FA, Mimics K, Pierri JN, et al. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22:2718-2729.
62. Miettinen PJ, Chin JR, Shum L, et al. 1999. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 22:69-73.
63. Mio H, Kagami N, Yokokawa S, et al. 1998. Isolation and characterization of a cDNA for human mouse, and rat full-length stem cell growth factor, a new member of C-type lectin superfamily. Biochem Biophys Res Commun 249:124-130.
64. Moiseiwitsch JR, Raymond JR, Tamir H, Lnuder JM. 1998. Regulation by serotonin of tooth-germ morphogenesis and gene expression in mouse mandibular explant cultures. Arch Oral Biol 43:789-800.
65. Montgomery RA, Dallman MJ. 1997 Semi-quantitative polymerase chain reaction analysis of cytokine and cytokine receptor gene expression during thymic ontogeny. Cytokine 9:717-726.
66. Moon RT, DeMarais A, Olson DJ. 1993. Responses to Wnt signals in vertebrate embryos may involve changes in cell adhesion and cell movement. J Cell Sci 17:183-188.
67. Nugent P, Greene RM. 1994. Interactions between the transforming growth factor beta (TGF-β) and retinoic acid signal transduction pathways in murine embryonic palatal cells. Differentiation 58:149-155.
68. Oshima RG, Baribault H, Caulin C. 1996. Oncogenic regulation and function of keratins 8 and 18. Cancer Metastasis Rev 15:445-471.
69. Pati D, Keller C, Groudine M, Plon SE. 1997. Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA. Mol Cell Biol 17:3037-3046.
70. Pelton RW, Hogan BL, Miller DA, Moses HL. 1990. Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol 141:456-460.
71. Peters H, Neubüser A, Kratochwil K, Balling R. 1998. Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev 12:2735-2747.
72. Pevny LH, Lovell-Badge R. 1997. Sox genes find their feet. Curr Opin Genet Dev 7:338-344.
73. Phillips RL, Ernst RE, Brunk B, et al. 2000. The genetic program of hematopoietic stem cells. Science 288:1635-1640.
74. Pisano MM, Greene RM. 1986. Hormone and growth factor involvement in craniofacial development. IRCS Med Sci 14:635-640.
75. Pisano MM, Greene RM. 1987. Epidermal growth factor potentiates the induction of ornithine decarboxylase activity by prostaglandins in embryonic palate mesenchymal cells: effects on cell proliferation and glycosaminoglycan synthesis. Dev Biol 122:419-431.
76. Ponsuksili S, Wimmers K, Adjaye J, Schellander K. 2001. Expression of homeobox-containing genes in cDNA libraries derived from cattle oocytes and preimplantation stage embryo. Mol Reprod Dev 60:297-301.
77. Potchinsky MB, Weston WM, Lloyd MR, Greene RM. 1997. TGF-beta signaling in murine embryonic palate cells involves phosphorylation of the CREB transcription factor. Exp Cell Res 231:96-103.
78. Potchinsky MB, Lloyd MR, Weston WM, Greene RM. 1998. Selective modulation of MAP kinase in embryonic palate cells. J Cell Physiol 176:266-280.
79. Pratt RM, King CT. 1972. Inhibition of collagen cross-linking associated with beta-aminopropionitrile-induced clef: palate in the rat. Dev Biol 27:322-328.
80. Pratt R, Kim C, Grove R. 1984. Role of glucocorticoids and epidermal growth factor in normal and abnormal palate development. In: Zimmerman E, editor. Current topics in developmental biology. New York: Academic Press, pp. 81-101.
81. Qiu M, Bulfone A, Ghattasa I, et al. 1997. Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches. Dev Biol 185:165-184.
82. Richards AJ, Martin S, Yates JR, et al. 2000. COL2A1 exon 2 mutations: relevance to the Stickler and Wagner syndromes. Br J Ophthalmol 84:364-371.
83. Rijli FM, Mark M, Lakkaraju S, et al. 1993. A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene. Cell 75:1333-1349.
84. Robinson GW, Mahon KA. 1994. Differential and overlapping expression domains of Dlx-2 and Dlx-3 suggest distinct roles for distal-less homeobox genes in craniofacial development. Mech Dev 48:199-215.
85. Rothman KJ, Moore LL, Singer M, et al. 1995. Teratogenicity of high vitamin A intake. N Engl J Med 33:1369-1415.
86. Ryan MC, Christiano AM, Engvall E, et al. 1996. The functions of laminins: lessons from in vivo studies. Matrix Biol 15:369-381.
87. Sandberg R, Yasuda R, Pankratz DG, et al. 2000. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 97:11038-11043.
88. Satokata I, Maas R. 1994. Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 6:348-356.
89. Schrier DJ, Phan SH, McGarry BM. 1983.The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis 127:614-617.
90. Shen MM, Wang H, Leder P. 1997. A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. Development 124:429-442.
91. Simin K, Scuderi A, Reamey J, et al. 2002. Profiling patterned transcripts in Drosophila embryos. Genome Res 12:1040-1047.
92. Steffek AJ, Verrusio AC, Watkins CA. 1972. Cleft palate in rodents after maternal treatment with various lathyrogenic agents. Teratology 5:33-38.
93. Tolarova MM, Cervenka J. 1998. Classification and birth prevalence of orofacial clefts. Am J Med Genet 75:126-137.
94. Trueblood NA, Xie Z, Communal C, et al. 2001. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88:1080-1087.
95. Warner DR, Pisano MM, Greene RM. 2002. Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. In Vitro Cell Dev Biol 38:48-53.
96. Warner DR, Pisano MM, Roberts EA, Greene RM. 2003. Identification of three novel Smad binding proteins involved in cell polarity. FEBS Lett 539:167-173.
97. Weston WM, Potchinsky MB, Lafferty CM, et al. 1998. Cross-talk between signaling pathways in murine embryonic palate cells: effect of TGF beta and cAMP on EGF-induced DNA synthesis. In Vitro Cell Dev Biol 34:74-78.
98. Weston WM, Freeman AB, Haberecht C, et al. 2002. Phosphatase regulation of gene expression during development of the palate. Life Sci 71:1849-1862.
99. Whiting J. 1997. Craniofacial abnormalities induced by the ectopic expression of homeobox genes. Mutat Res 396:97-112.
100. Wood HB, Episkopou V. 1999. Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech Dev 86:197-201.
101. Wu J, Li J, Huang KP, Huang FL. 2002. Attenuation of protein kinase C and cAMP-dependent protein kinase signal transduction in the neurogranin knockout mouse. J Biol Chem 277:19498-19505.
102. Yamaguchi Y, Shirakabe K, Shibava H, et al. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGFβ signal transduction. Science 270:2008-2011.
103. Yang XL, Matsuura H, Fu Y, et al. 2000. MFH-1 is required for bone morphogenetic protein-2-induced osteoblastic differentiation of C2C12 myoblasts. FEBS Lett 470:29-34.
104. Yokouchi Y, Sakiyama J, Kameda T, et al. 1996. BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 122:3725-3734.
105. Zhao Y, Guo YJ, Tomac AC, et al. 1999. Isolated cleft palate in mice with a targeted mutation of the LIM homeobox gene Lhx8. Proc Natl Acad Sci USA 96:15002-15006.
106. Zondag GCM, Evers EE, ten Klooster JP, et al. 2000. Oncogenic ras down-regulates rac activity, which leads to increased rho activity and epithelial-mesenchymal transition. J Cell Biol 49:775-781.